UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2781-2797

2014

Volltextzugriff (PDF)

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons

The Journal of Frailty & Aging, 2019-01, Vol.8 (1), p.10-16

2019

Volltextzugriff (PDF)

Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection

Microbiology spectrum, 2024-03, Vol.12 (3), p.e0300923-e0300923

2024

Volltextzugriff (PDF)

Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals

Infection, 2013-12, Vol.41 (6), p.1097-1102

2013

Volltextzugriff (PDF)

The use of human immunodeficiency virus resistance tests in clinical practice

Clinical microbiology and infection, 2010-10, Vol.16 (10), p.1511-1517

2010

Volltextzugriff (PDF)

Antiretrovirus Activity of a Novel Class of Acyclic Pyrimidine Nucleoside Phosphonates

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2185-2193

2002

Volltextzugriff (PDF)

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

Archives of virology, 2011-07, Vol.156 (7), p.1235-1243

2011

Volltextzugriff (PDF)

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Clinical microbiology and infection, 2017-12, Vol.23 (12), p.935-940

2017

Volltextzugriff (PDF)

Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I

The Journal of infectious diseases, 2020-09, Vol.222 (7), p.1108-1116

2020

Volltextzugriff (PDF)

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs

Antiviral research, 2011-11, Vol.92 (2), p.382-385

2011

Volltextzugriff (PDF)

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Journal of clinical virology, 2023-11, Vol.168, p.105551-105551, Article 105551

2023

Volltextzugriff (PDF)

Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.413-422

1998

Volltextzugriff (PDF)

HIV MDR is still a relevant issue despite its dramatic drop over the years

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1301-1310

2020

Volltextzugriff (PDF)

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Journal of medicinal chemistry, 1994-11, Vol.37 (24), p.4185-4194

1994

Volltextzugriff (PDF)

Mechanism of Anti-HIV Action of Masked Alaninyl d4T-Mp Derivatives

Proceedings of the National Academy of Sciences - PNAS, 1996-07, Vol.93 (14), p.7295-7299

1996

Volltextzugriff (PDF)

Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance

Clinical microbiology and infection, 2020-09, Vol.26 (9), p.1266-1268

2020

Volltextzugriff (PDF)

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy

AIDS research and human retroviruses, 2009-02, Vol.25 (2), p.157-164

2009

Volltextzugriff (PDF)

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

Clinical microbiology and infection, 2019-07, Vol.25 (7), p.906.e1-906.e7

2019

Volltextzugriff (PDF)

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

Biochemical and biophysical research communications, 1989-12, Vol.165 (3), p.1375-1381

1989

Volltextzugriff (PDF)

OC-66 Socio-demographic, clinical and therapeutic features of persons with HIV (PWH) currently in care in Italy: data from the ICONA cohort

Sexually transmitted infections, 2024-06, Vol.100 (Suppl 1), p.A64-A65

2024

Volltextzugriff (PDF)

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor

Clinical microbiology and infection, 2016-11, Vol.22 (11), p.946.e1-946.e8

2016

Volltextzugriff (PDF)

Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy

Journal of Virology, 2006-11, Vol.80 (21), p.10335-10345

2006

Volltextzugriff (PDF)

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1865-1873

2015

Volltextzugriff (PDF)

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (3), p.855-865

2017

Volltextzugriff (PDF)

Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life

Clinical microbiology and infection, 2017-10, Vol.23 (10), p.777.e1-777.e4

2017

Volltextzugriff (PDF)

1 – 25 von 444

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(389)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons

Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection

Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals

The use of human immunodeficiency virus resistance tests in clinical practice

Antiretrovirus Activity of a Novel Class of Acyclic Pyrimidine Nucleoside Phosphonates

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus

HIV MDR is still a relevant issue despite its dramatic drop over the years

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Mechanism of Anti-HIV Action of Masked Alaninyl d4T-Mp Derivatives

Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

OC-66 Socio-demographic, clinical and therapeutic features of persons with HIV (PWH) currently in care in Italy: data from the ICONA cohort

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor

Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life

Aktive Filter

Suchergebnisse filtern